Medistim ASA (STO:MEDIO)

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of SEK 4.68 billion. The enterprise value is 4.55 billion.

Market Cap	4.68B
Enterprise Value	4.55B

Important Dates

The last earnings date was Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	18.27M
Shares Outstanding	n/a
Shares Change (YoY)	-0.17%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	2.93%
Owned by Institutions (%)	86.09%
Float	12.61M

Valuation Ratios

The trailing PE ratio is 34.82 and the forward PE ratio is 30.75.

PE Ratio	34.82
Forward PE	30.75
PS Ratio	7.49
PB Ratio	11.85
P/TBV Ratio	14.63
P/FCF Ratio	26.82
P/OCF Ratio	25.96
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.97, with an EV/FCF ratio of 26.08.

EV / Earnings	33.87
EV / Sales	7.33
EV / EBITDA	23.97
EV / EBIT	27.00
EV / FCF	26.08

Financial Position

The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.05.

Current Ratio	3.33
Quick Ratio	2.03
Debt / Equity	0.05
Debt / EBITDA	0.11
Debt / FCF	0.12
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 34.58% and return on invested capital (ROIC) is 26.35%.

Return on Equity (ROE)	34.58%
Return on Assets (ROA)	21.07%
Return on Invested Capital (ROIC)	26.35%
Return on Capital Employed (ROCE)	40.19%
Revenue Per Employee	4.06M
Profits Per Employee	872,489
Employee Count	154
Asset Turnover	1.24
Inventory Turnover	0.77

Taxes

In the past 12 months, Medistim ASA has paid 42.34 million in taxes.

Income Tax	42.34M
Effective Tax Rate	23.96%

Stock Price Statistics

The stock price has increased by +60.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+60.34%
50-Day Moving Average	224.52
200-Day Moving Average	n/a
Relative Strength Index (RSI)	66.74
Average Volume (20 Days)	207

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of SEK 624.70 million and earned 134.36 million in profits. Earnings per share was 7.35.

Revenue	624.70M
Gross Profit	506.18M
Operating Income	169.55M
Pretax Income	176.70M
Net Income	134.36M
EBITDA	182.67M
EBIT	169.55M
Earnings Per Share (EPS)	7.35

Balance Sheet

The company has 148.74 million in cash and 20.10 million in debt, giving a net cash position of 128.64 million.

Cash & Cash Equivalents	148.74M
Total Debt	20.10M
Net Cash	128.64M
Net Cash Per Share	n/a
Equity (Book Value)	394.91M
Book Value Per Share	21.61
Working Capital	281.44M

Cash Flow

In the last 12 months, operating cash flow was 180.21 million and capital expenditures -5.72 million, giving a free cash flow of 174.49 million.

Operating Cash Flow	180.21M
Capital Expenditures	-5.72M
Free Cash Flow	174.49M
FCF Per Share	n/a

Margins

Gross margin is 81.03%, with operating and profit margins of 27.14% and 21.51%.

Gross Margin	81.03%
Operating Margin	27.14%
Pretax Margin	28.29%
Profit Margin	21.51%
EBITDA Margin	29.24%
EBIT Margin	27.14%
FCF Margin	27.93%

Dividends & Yields

Medistim ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	76.86%
Buyback Yield	0.17%
Shareholder Yield	0.17%
Earnings Yield	2.87%
FCF Yield	3.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6